FTLF FitLife Brands, Inc.
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
What changed
Recent filings, trades and moves
- Industry (SIC)
- MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (2833) · industry map
- Exchange
- XNAS
- Market Cap
- $0.1B
- Employees
- 81
- List Date
- 2007-09-25
- CIK
- 0001374328
- Last Earnings
- Aug 13
- Headquarters
- Omaha, NE
- Homepage
- https://www.fitlifebrands.com
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Dr. Tobias, MusclePharm, Irwin Naturals, Applied Nutrition, Isatori, and Nature's Secret brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care an…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|
| Jan | -17.37% | 6.42% | 14.06% | -4.48% | 0.89% | -0.10% |
| Feb | -4.76% | 11.11% | 2.12% | -4.03% | -7.52% | -0.62% |
| Mar | -13.12% | -11.84% | 5.42% | -19.87% | -5.84% | -9.05% |
| Apr | -0.55% | 1.49% | 13.23% | 27.43% | -23.55% | 3.61% |
| May | -2.79% | 0.00% | 10.59% | -4.75% | 10.13% | 2.64% |
| Jun | -2.33% | 6.25% | 0.91% | -12.09% | 11.10% | 0.77% |
| Jul | 26.19% | 13.65% | -1.49% | -11.60% | -9.91% | 3.37% |
| Aug | 24.44% | -9.94% | 3.78% | 48.96% | 1.46% | 13.74% |
| Sep | -4.76% | 1.44% | -1.71% | 10.19% | -4.02% | 0.23% |
| Oct | 6.00% | 10.82% | -3.21% | -2.94% | -15.52% | -0.97% |
| Nov | -5.66% | -13.22% | 6.07% | -3.42% | -16.56%* | -6.56% |
| Dec | 6.33% | -3.54% | -2.25% | -10.48% | -- | -2.49% |
| Total | 2.66% | 8.27% | 56.47% | -4.56% | -49.18% | 2.73% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report: FTLF
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers:
- Technical indicators suggest a range-bound market with a slight bullish bias
- Recent news headlines are neutral, providing no significant catalysts
- Risk metrics indicate low volatility and correlation with the market
Primary Risks:
- Lack of clear direction in the stock price
- Potential for increased volatility if earnings or other key events trigger a move
Investment Thesis: FTLF is currently range-bound, with technical indicators suggesting a slight bullish bias. The stock's low volatility and correlation with the market make it an attractive option for investors seeking to minimize risk. However, the lack of clear direction in the stock price means that any potential catalysts could trigger significant moves.
Recent News Sentiment Impact: The recent news headlines are neutral, providing no significant catalysts for the stock price. The absence of bearish or bullish sentiment means that the market is likely to remain range-bound.
Technical Analysis
Trend Direction:
- Short-term: Range-bound
- Medium-term: Slightly Bullish
- Long-term: Neutral
Support/Resistance Levels:
- SMA 20: $10.44 (support)
- SMA 50: $10.65 (resistance)
- Upper Bollinger Band: $11.50 (resistance)
Momentum Signals:
- RSI interpretation: Neutral (42.26%)
- MACD signal: Bearish (Histogram: -0.21)
- Bollinger Bands position: Squeeze
Volume Analysis:
- Volume SMA 20: 12485.95
- On-Balance Volume (OBV): -428570.31 (negative)
News & Sentiment Analysis
Recent Headlines Summary: The recent news headlines are neutral, with no significant events or announcements impacting the stock price.
Sentiment Assessment: The sentiment analysis is neutral, with no clear bullish or bearish bias evident in the recent news headlines.
Catalyst Identification: No significant catalysts are currently identified that could impact the stock price.
Market Narrative: The market narrative remains neutral, with no clear direction or trend evident in the technical indicators.
Risk & Volatility Assessment
Risk Metrics:
- Beta: 0.24 (low risk)
- Alpha: -0.30
- Correlation: 0.06 (low correlation)
Volatility Regime: The current volatility regime is low, with the stock moving less than the market.
Options Market Signals: No options data available
Downside Protection: Support levels are present at SMA 20 ($10.44), providing some downside protection for investors.
Market Context & Positioning
Sector Performance: FTLF's performance is in line with its sector and market.
Institutional Activity: Volume patterns suggest institutional interest, but no clear bias or direction is evident.
Correlation Analysis: The stock moves less than the market (R-squared interpretation), indicating a low correlation.
Relative Valuation: The stock is positioned within its trading range, with no clear undervalued or overvalued signal present.
Key Levels & Action Items
Critical Price Levels:
- SMA 20: $10.44 (support)
- Upper Bollinger Band: $11.50 (resistance)
Breakout/Breakdown Levels: No clear breakout or breakdown levels are identified at this time.
Time-Sensitive Catalysts: No earnings dates, FDA approvals, product launches, or other significant events are currently scheduled to impact the stock price.
Risk Management: Stop-loss levels can be set at SMA 20 ($10.44) to limit potential losses.
This report provides a comprehensive analysis of FTLF, incorporating technical indicators, options metrics, beta analysis, market data, and recent news headlines. The assessment is neutral, with no clear direction or trend evident in the technical indicators. The stock's low volatility and correlation with the market make it an attractive option for investors seeking to minimize risk. However, the lack of clear direction means that any potential catalysts could trigger significant moves.
FTLF Options Activity & IV Rank
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
IV(call wing) − IV(ATM), in vol pointsThe same measure on the upside: how the OTM call is priced against the at-the-money strike.
- Negative (typical) — calls trade below ATM for most stocks and indices, so the sign alone says little.
- Percentile vs own history: high = upside calls unusually rich for this name (squeezes, takeover talk, commodity supply scares); low = calls cheaper than usual.
Put or call vs ATM tells you how expensive that tail is. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Loading the implied volatility surface…
Loading the implied volatility smile…
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Low volatility - stock moves less than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $258K | #3406 of 3716 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
FTLF Institutional Ownership (13F)
Filings for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
FTLF Insider Trading (Form 4)
Latest: 2026-09-02| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Jakob York | CHIEF FINANCIAL OFFICER | Grant (A) | +4,000 opt | — | EDGAR | |
| 2026-08-21 | Shannon K. Pappas | Director | Buy (P) | +1,000 | $10.25 | $10.2K | EDGAR |
| 2026-05-19 | Ryan P. Hansen | President | Grant (A) | +125,000 opt | — | EDGAR | |
| 2026-04-20 | Seth Yakatan | Director | Buy (P) | +164 | $15.36 | $2.5K | EDGAR |
| 2026-04-14 | Grant Robert Dawson | Director | Buy (P) | +3,000 | $9.98 | $29.9K | EDGAR |
| 2026-04-14 | Matthew Lingenbrink | Director | Buy (P) | +3,000 | $9.76 | $29.3K | EDGAR |
| 2025-09-08 | Jakob York | CHIEF FINANCIAL OFFICER | Grant (A) | +4,000 opt | — | EDGAR | |
| 2025-04-16 | Matthew Lingenbrink | Director | Buy (P) | +3,000 | $12.17 | $36.5K | EDGAR |
| 2025-04-16 | Todd Ordal | Director | Buy (P) | +300 | $12.07 | $3.6K | EDGAR |
| 2025-04-02 | Judd Dayton | CHIEF EXECUTIVE OFFICER | Exer (M) | +144,000 | $2.62 | $377.3K | EDGAR |
| 2025-04-02 | Matthew Lingenbrink | Director | Buy (P) | +2,800 | $12.17 | $34.1K | EDGAR |
| 2025-03-28 | Grant Robert Dawson | Director | Award (A) | +2,144 | $12.68 | $27.2K | EDGAR |
| 2025-01-16 | Todd Ordal | Director | Buy (P) | +150 | $30.37 | $4.6K | EDGAR |
| 2025-01-02 | Judd Dayton | CHIEF EXECUTIVE OFFICER | Exer (M) | +6,200 | $0.70 | $4.3K | EDGAR |
| 2024-09-03 | Jakob York | CHIEF FINANCIAL OFFICER | Grant (A) | +2,000 opt | — | EDGAR |
FTLF Insider Holdings
6 insiders · @ $6.73| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Judd Dayton | CHIEF EXECUTIVE OFFICER | 5,288,658 | $35.59M | $0 | 4 | 2025-04-02 |
| 2 | Grant Robert Dawson | Director | 158,000 | $1.06M | $29.9K | 2 | 2026-04-14 |
| 3 | Todd Ordal | Director | 62,488 | $420.5K | $8.2K | 2 | 2025-04-16 |
| 4 | Matthew Lingenbrink | Director | 8,800 | $59.2K | $99.9K | 3 | 2026-04-14 |
| 5 | Shannon K. Pappas | Director | 1,000 | $6.7K | $10.2K | 1 | 2026-08-21 |
| 6 | Seth Yakatan | Director | 593 | $4.0K | $2.5K | 1 | 2026-04-20 |
FTLF Board & Officers
As of SEC filings through Sep 2, 2026Directors 4
- Grant Robert Dawson · since Nov 1, 2013
- Seth Yakatan · since Sep 30, 2015
- Matthew Lingenbrink · since Aug 13, 2024
- Shannon K. Pappas · since Apr 25, 2025
Officers 2
- Ryan P. Hansen · Executive Vice President · since Apr 29, 2025
- Jakob York · Chief Financial Officer · since Aug 15, 2022
Changes in the last 10 years (11)
| Apr 29, 2025 | Ryan P. Hansen became Executive Vice President |
| Apr 25, 2025 | The company announced the departure of Todd Ordal from the board in an SEC filing |
| Apr 25, 2025 | Shannon K. Pappas became a director |
| Aug 13, 2024 | Matthew Lingenbrink became a director |
| Jan 3, 2023 | Patrick John Phillip Ryan became Chief Retail Officer |
| Aug 15, 2022 | Jakob York became Chief Financial Officer |
| Feb 18, 2019 | Susan Kinnaman became Chief Financial Officer |
| Aug 2, 2018 | Judd Dayton listed as Chief Executive Officer (previously Interim CEO) in SEC filings |
| May 30, 2018 | Judd Dayton first listed as a 10% owner in an SEC filing |
| Mar 22, 2018 | Judd Dayton first listed as Interim CEO in an SEC filing |
| Jun 22, 2017 | Judd Dayton became a director |
Not reported recently (5)
- Judd Dayton · Last reported as a director in an SEC filing dated Apr 2, 2025
- Patrick John Phillip Ryan · Last reported as Chief Retail Officer in an SEC filing dated Jun 4, 2024
- Lewis Jaffe · Last reported as a director in an SEC filing dated Aug 9, 2023
- Susan Kinnaman · Last reported as Chief Financial Officer in an SEC filing dated Apr 20, 2021
- Michael S Abrams · Last reported as Chief Financial Officer in an SEC filing dated Feb 14, 2017
| Filing Date | Accession | Link |
|---|
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $683,131 | — | 2026-10-31 |
| 2 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $324,662 | — | 2026-10-31 |
| 3 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.01% | $79,956 | $1.2B | 2026-11-17 |
| 4 | DFUS Dimensional US Equity Market ETF | Dimensional | 0.00% | $8,052 | $20.9B | 2026-11-17 |
| 5 | IVSS Applied Finance IVS US SMID ETF | Nport | 0.01% | $3,292 | — | 2026-06-30 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
FTLF vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| BTSG BrightSpring Health Services, Inc. Commo | $13.6B | 34.7 | +26.0% | +66.5% | 20 |
| ENSG The Ensign Group, Inc. | $10.7B | 26.3 | +17.5% | +1.7% | 37 |
| STRL Sterling Infrastructure, Inc. Common Sto | $8.4B | 15.4 | +93.1% | −14.0% | 55 |
| AMRX Amneal Pharmaceuticals, Inc. Class A Com | $7.6B | 50.8 | +8.9% | +68.6% | 8 |
| PACS PACS Group, Inc. | $7.3B | 23.9 | +11.0% | +9.0% | 9 |
| LNTH Lantheus Holdings, Inc | $6.7B | 25.0 | +2.4% | +51.8% | 9 |
| SEZL Sezzle Inc. Common Stock | $5.4B | 28.2 | +38.9% | +126.2% | 23 |
| CPRX Catalyst Pharmaceutical Inc. | $3.9B | 18.1 | +11.7% | +36.0% | — |
| FTLF FitLife Brands, Inc. Common Stock | $65M | — | — | −57.3% | — |
| Peer median | $7.5B | 25.6 | +14.6% | +43.9% | 20 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.